Text size

Donors are needed to treat Covid-19 with blood plasma

published on 4/23/20 4:47 PM

Two teams at the Bulgarian Academy of Sciences are looking for a cure for the novel coronavirus. One team is working on developing a therapy and the other team on developing is a vaccine, said the head of the National Crisis Headquarters Gen. Ventsislav Mutafchijsky. Their work is in a very early stage.

Using blood plasma to treat Covid-19 in the country is not so easy, the specialists from the National Crisis Headquarters said. In order to make a plasma pool, between 2,500-5,000 donors are needed. Given the number of currently recovered patients in Bulgaria, this is impossible, they said.

Still, Bulgaria's health authorities are ready to introduce the blood plasma treatment, as well.

Последвайте ни и в Google News Showcase, за да научите най-важното от деня!

Radio Bulgaria News Up-to-date information blood plasma coronavirus Covid-19 donors

More from category

Bulgaria's President opens business forum in Ho Chi Minh during his Vietnam visit

At the opening of a business forum in Ho Chi Minh City during his official visit to Vietnam, Bulgarian President Rumen Radev pointed out that Bulgaria can offer a wide range of opportunities for developing mutually beneficial cooperation...

published on 11/27/24 1:46 PM

The Prosecutor's College allowed Sarafov to a hearing before the Supreme Judicial Council's Plenum

The Prosecutor's College of the Supreme Judicial Council approved the reports of the Commission on Attestation and Competitions and the Commission for Professional Ethics regarding the candidacy of Borislav Sarafov for Chief Prosecutor, reported BTA...

published on 11/27/24 12:25 PM

Sofia and Ho Chi Minh exchange letters of intent for cooperation

Sofia and Vietnam’s city of Ho Chi Minh exchanged letters of intent for cooperation. Sofia Mayor Vassil Terziev and Nguyen Van Dung, Vice Chairman of Ho Chi Minh City Municipal People’s Committee, exchanged the documents in the presence of Bulgarian..

published on 11/27/24 12:07 PM